08.04.22 -- Strategic Outsourcing Demand: Selecting A CDMO

Whether you’re developing a drug substance or finished dosage form, you need to complete the project before you use all your funds, so choosing a CMO or CDMO is a big decision. Before you sign on the dotted line, do a little digging to unearth potential costs that could turn your development program into a cash-burning exercise.

New drugs acquired via mergers, acquisitions, or licensing agreements often come with an entourage of contract manufacturers. Complex CMO networks require many resources to manage and prevent purchasing and operating at scale. Yet, the process of consolidating is daunting. Where do you begin?

As strategic outsourcing demand grows more powerful, so have CDMO offerings. Some of pharma’s legacy brands developed their own innovative response to the market’s potential, creating a distinct class of contract development and manufacturing services suppliers immersed in Big Pharma.